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Embolic complication of
Tako-Tsubo cardiomyopathy
Sir,
We present a case of an 81-year-old female present-
ing with one week worsening dyspnea on exertion
Figure 1. Electrocardiogram showing ST depression in the inferolateral leads and ST elevation in aVR and V1-2.
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and a cold, discolored, numb foot for 2 days. The
patient denied chest pain but reported a history con-
sistent with melanotic stools. Her hemoglobin was
found to be 3.5 in the emergency department.
Electrocardiogram showed 0.5–1.0mm ST depres-
sion in leads II, III, aVF, V4-6 and ST elevation in
aVR and V1-2 (Figure 1). Echocardiogram demon-
strated a dilated left ventricle with a severely
reduced ejection fraction but preserved basal con-
tractile function (Figure 2A: end diastole and B: end
systole). Catheterization demonstrated no epicardial
coronary artery disease, but occlusion of the distal
right popliteal and anterior tibial arteries (Figure 3).
The patient was treated with heparin, aspirin,
beta-blocker and angiotensin converting enzyme
inhibitor. The patient eventually required amputa-
tion of her right lower extremity. Gastroenterological
workup revealed a colon adenocarcinoma
which was successfully resected. Follow-up echo-
cardiogram 4 weeks later demonstrated normal
left ventricular ejection fraction (Figures 4A: end
diastole and 4B: end systole). The final diagnosis
was tako-tsubo cardiomyopathy, precipitated
by severe anemia, leading to distal thrombus
embolization. Haghi et al.1 reported in this journal
the incidence of left ventricular thrombus in the
setting of tako-tsubo cardiomyopathy to be 8%.
However, they reported no episodes of peripheral
embolization due to the left ventricular thrombus.
This case illustrates the potential complications
associated with thrombus formation found to
occur in a minority of tako-tsubo cardiomyopathy
cases.
Figure 2. Echocardiogram (apical four chamber view) demonstrating a dilated left ventricle with severely reduced ejection
fraction but preserved basal contractile function. A: end diastole and B: end systole.
Figure 3. Catheterization demonstrating occlusion of the
distal right popliteal and anterior tibial arteries.
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Profound hypokalaemia mimicking
acute myocardial infarction
Sir,
A 70-year-old female, recently diagnosed with
metastatic rectal carcinoma requiring a de-function-
ing colostomy, presented to her local emergency
department with chest pain in keeping with myocar-
dial ischaemia. An initial electrocardiogram (ECG)
demonstrated lateral ST-segment elevation and she
was urgently transferred to the regional percuta-
neous coronary intervention (PCI) centre. On arrival
her pain had settled. Emergency coronary angiogra-
phy revealed single vessel disease in the form of
a heavily calcified non-flow limiting stenosis in
the mid-portion of the right coronary artery.
Echocardiography demonstrated a lateral wall
motion abnormality with no evidence of malignant
invasion of the pericardium or a pericardial effusion.
Troponin I was raised at 1.9 mg/l confirming a myo-
cardial infarction and routine biochemistry revealed
a plasma potassium concentration of 2.9 mmol/l, for
which she was commenced on an intravenous
potassium chloride infusion. The following day she
developed recurrent episodes of ventricular tachy-
cardia (VT) and repeat ECG demonstrated gross
global ST-segment elevation (Figure 1). She was
immediately taken back to the catheterization
laboratory, but angiographic appearances were
unchanged from the previous day. Biochemistry
now revealed profound hypokalaemia (2.1 mmol/l)
despite replacement and hypocalcaemia (corrected
1.75 mmol/l). On further questioning she had
noticed greatly increased output from her stoma
over the previous week. Her rhythm stabilized and
the ECG changes resolved over 24 h following
aggressive intra-venous replacement of electrolytes
up to normal levels.
This lady initially presented with ischaemic chest
pain, lateral ECG changes and a correlating wall
motion abnormality on echocardiography.
Coronary artery disease was confirmed at angiogra-
phy, but there was no evidence of an acute flow
limiting lesion. Whether this was due to coronary
vasospasm secondary to electrolyte disturbance or
a self-resolving plaque rupture is unclear. Her dete-
rioration the following day with the development of
Figure 4. Echocardiogram (apical four chamber view) 4 weeks later demonstrating normal left ventricular ejection fraction.
A: end diastole and B: end systole.
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